3Elliott PM, Tattersall MH, Coppleson M, et al. Changing character of cervical cancer in young women. BMJ, 1989,298 (6669) :288 - 290.
4Ostor AG, Natural history of cervical intraepithelial neoplasia:a critical review. Int J Gynecol Pathol, 1993,12 (2) : 186 - 192.
5Koss LG. The Papanicolaou test for cervical cancer detetion. Atriumph and a tragedy. JAMA, 1989,261 ( 5 ) :737 - 743.
6Hutchinson ML, Isenstein LM, Goodman A, et al. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor. Am J Clin Pathol, 1994,101 (2) :215 - 219.
7Zielinski GD, Snijders PJ, Rozendaal L, et at. High - risk HPV testing in women with borderline and mild dyskaryosis: longterm follow - up data and clinical relevance. J Pathol,2001,195 :300 - 306.
4Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin, 1999, 49(1):33-64.
5Franeo EL, Duarte-Franco E, Ferenezy A. Cervical cancer:epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 2001, 164(7):1017-1025.
6Zlaang ZF, Parkin DM, Yu SZ, et al. Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer, 1989, 43:762-767.
7International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risks to humans,human papillomaviruses. Vol 64. Lyon: IARC Press, 1995.
8Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papiUomavims in cervical cancer, the IARC multicentric case-control study. Lancet, 2002, 359:1093-1101.
9Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer, 1995, 76(10 Suppl):1888-1901.
10David ME. Screening for cervical cancer. Ann Intern Med, 1990, 113:214-226.
